early in the therapy ( 24 to 96 hr after commencing treatment ) changes occur , including irregularity of the nuclear envelope , enlargement of the nuclei and nucleoli , temporary disappearance of fibrillar centres , followed by temporary disappearance of fibrillar centres , followed by temporary increase in nuclear bodies and increasing amounts of heterochromatin .
C0007610
nuclei
C0019397
heterochromatin